• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Participating Faculty: Improving Clinical and Managed Care Outcomes in Rheumatoid Arthritis: A Focus on Comparative Effectiveness of Current Treatments

Publication
Article
Supplements and Featured PublicationsImproving Clinical and Managed Care Outcomes in Rheumatoid arthritis: a Focus on Comparative Effecti
Volume 18
Issue 13 Suppl

This supplement to The American Journal of Managed Care provides an overview of the diagnosis, pathophysiology, epidemiology, symptoms, assessment, and prognosis of rheumatoid arthritis (RA). It reviews the goals of treatment, approach to treatment, and monitoring of outcomes in patients with RA with currently available therapies. Special focus is placed on the role of newer biologic agents and their comparative data. This supplement also describes the direct and indirect costs associated with RA, with a focus on treatment-related costs, the role of specialty pharmacy and managed care, and mechanisms to provide disease management that optimizes economic outcomes.Faculty

William J. Cardarelli, PharmD

Director of Pharmacy Revenue and Supply

Atrius Health

Harvard Vanguard Medical Associates

Watertown, Massachusetts

Allan Gibofsky, MD, JD, FACP, FCLM

Professor of Medicine and Public Health

Weill Medical College of Cornell University

Attending Rheumatologist

Hospital for Special Surgery

New York, New York

Editorial Support

Andrew Scott Mathis, PharmD

Pharmacy Department

Monmouth Medical Center

Long Branch, New Jersey

Faculty Disclosures

These faculty have disclosed the following relevant commercial financial relationships or affiliations in the past 12 months.

William J. Cardarelli, PharmD, has no relevant financial relationships with commercial interests to disclose.

Allan Gibofsky, MD, JD, FACP, FCLM

Consultant/advisory board, honoraria, lectureship, stock ownership: Abbott, Amgen, Genentech, Pfizer, and UCB

Stock ownership: Johnson & Johnson; GlaxoSmithKline

Andrew Scott Mathis, PharmD, has no relevant financial relationships with commercial interests to disclose.

The American Journal of Managed Care

Publishing Staff—Jeff D. Prescott, PharmD, RPh; Kara Guarini, MS; and Ida Delmendo have no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Office of Continuing Professional Education and Physicians’ Education Resource, LLC

Planning Staff—Judy V. Lum, MPA; and Elena Beyzarov, PharmD, have no relevant financial relationships with commercial interests to disclose.

Signed disclosures are on file at the office of The American Journal of Managed Care, Plainsboro, New Jersey.

Opinions expressed by authors, contributors, and advertisers are their own and not necessarily those of Clinical Care Targeted Communications, LLC, d/b/a Managed Care & Healthcare Communications, LLC, the editorial staff, or any member of the editorial advisory board. Clinical Care Targeted Communications, LLC, d/b/a Managed Care & Healthcare Communications, LLC, is not responsible for accuracy of dosages given in articles printed herein. The appearance of advertisements in this publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality, or safety. Clinical Care Targeted Communications, LLC, d/b/a Managed Care & Healthcare Communications, LLC, disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the articles or advertisements.

© 2024 MJH Life Sciences
AJMC®
All rights reserved.